CTY City Therapeutics, Inc. - Common Stock
NASDAQCTY Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
CTY Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Company insiders 6 insiders · 1 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Andrew C. Orth | President & CEO | Oct. 19, 2026 A | · | 0 | 0 | $0 |
| Robert Nelsen | Director | Oct. 19, 2026 C | 13,692,507 | 1 | 0 | $3,060,000 |
| John Maraganore | Director | Oct. 19, 2026 C | 1,470,692 | 0 | 0 | $0 |
| Ron M Philip | Director | Oct. 15, 2026 A | · | 0 | 0 | $0 |
| Sara Nochur | Director | Oct. 15, 2026 A | · | 0 | 0 | $0 |
| Barry E Greene | Director | Oct. 15, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.